CBD patches are becoming increasingly popular, but how do they compare to CBD oil?
Innovation in the legal cannabis industry has led to a plethora of options when it comes to using CBD. One that has become increasingly popular is the topical CBD patch, but how does it compare to a good old CBD oil?
How CBD patches work
Patches are arguably the most convenient way to reap the benefits of cannabidiol.
One simply needs to apply a patch to an area of skin (preferably hairless), then CBD will be gradually absorbed by the body for a set period of time.
This makes them a discreet option for busy people who would rather not waste time applying drops in the mirror.
There are different types of technology used in patches, but one of the most common is the Matrix system.
The Matrix system involves infusing a high concentration of CBD into the patch material which tends to be activated by the natural heat of the skin. Once activated, the CBD is gradually released from a concentration gradient.
A concentration gradient takes advantage of the natural tendency of compounds to disperse from a highly concentrated area (the patch) to a lesser concentrated area (the skin).
CBD patches bypass the liver, which means higher concentrations of CBD are absorbed by the body than most orally-ingested CBD products. This rate of absorption is known as bioavailability.
How do patches compare to CBD oil?
Despite the fact that CBD patches are more convenient and have higher bioavailability than CBD oils, the ideal product really depends on the individual.
CBD oils, especially full-spectrum options, contain a whole lot more than CBD. Cannabinoids, terpenes, flavonoids, omega fatty acids, polyphenols, chlorophyll and other hemp compounds can all play an important role in enhancing wellbeing.
These compounds also seem to have a synergistic relationship known as the ‘entourage effect, which could help to produce effects that are difficult for CBD patches to achieve.
Overall, patches seem to be the better option for those looking to benefit from pure CBD alone, but oils have more potential to improve a range of other health and wellbeing outcomes. Perhaps combining both could be optimal?
Find out more at www.brownscbd.co.uk
The ‘mother of all cannabinoids’ – what is CBG?
New studies show the potential benefits of this lesser-known cannabinoid
There are hundreds of cannabinoids in cannabis from CBD to THC. Although CBD feels like its popping up in everything lately, the industry is looking for the next big thing – cannabigerol (CBG).
What is CBG?
Cannabigerol is one of the cannabinoids found in cannabis. It is sometimes referred to as ‘the mother of all cannabinoids’ because it is the precursor to CBD. Other cannabinoids are derived from cannabigerolic acid (CBGA), an acidic form of CBG.
There is very little CBG in plants often as low as one per cent so it makes CBG more expensive than CBD products. CBD is much more available in plants at 20 to 25 per cent. CBG tends to be made from younger plants which contain a higher percentage. THC and CBD both begin life as CBGA before maturing and THC goes on to become CBN in older plants.
It is thought to work the same as CBD in that it interacts with our endocannabinoid system via receptors that are found all over the body. In particular, it may bind to the CB1 receptors in our nervous system or CB2 receptors in our immune system.
It is thought to potentially strengthen the function of anandamide which is a neurotransmitter that affects our pleasure and motivation. It also regulates appetite, sleep and pain relief.
What is CBG good for?
There have been a few studies that show the potential benefits of CBG.
A study from 2020 revealed that CBG may help to fight against antibiotic resistance.
Researchers identified CBG as an antibacterial compound that may serve as a lead for new drug development. Their study found that it was not only antibacterial but it was effective in mice fighting a resilient form of bacteria referred to as methicillin-resistant Staphylococcus aureus (MRSA).
A more recent study from 2021 revealed that it may help in the fight against obesity.
The researchers synthesised three different CBG derivatives, HUM 223, HUM 233, HUM 234. In tests on mice, they discovered that HUM-234 may offer potential as an obesity treatment drug.
The mice were divided into groups for the study; one given just a high-fat diet (HFD), another given an HFD and CBG then one given an HFD and HUM-234. The researchers discovered that in comparison to the other groups, the mice on HUM-234 gained weight much slower and their livers were in a better condition with less fat build-up.
The researchers wrote: “The high-fat diet mice showed liver steatosis while the HUM 234 treated mice livers revealed almost no steatosis. The livers of the mice on CBG showed almost the same levels of steatosis as those on the high-fat diet.”
Should I take CBD or CBG?
Why not combine both? CBD and CBG can actually combine to offer potentially better benefits together. This is often referred to as the entourage effect. Each cannabinoid has unique effects and benefits, and their behaviour may when combined with other compounds.
That said, if you do prefer the idea of one or the other then these are some of the benefits of CBG
CBG for appetite stimulation
A study from 2017 revealed that a form of CBG with no THC was an effective appetite stimulant in rats. It is thought that it may be able to help with cachexia, the muscle-wasting and severe weight loss associated with cancer.
CBG for glaucoma
In one study, researchers treating cats with glaucoma used drops with CBG and Δ9-tetrahydrocannabinol. They noticed there was a reduction in eye pressure but an increase in aqueous humor outflow which is a liquid that provides nutrition to the eyes.
CBG for Huntingdon Disease
In another study from 2015, researchers discovered that CBG may have neuroprotective properties when it comes to Huntington disease. They examined mice with an experimental model of Huntington Disease. They noted that CBG may act as a neuroprotectant minding nerve cells from damage while improving motor defects. It also helped to preserve striatal neurons against 3-nitropropionic acid toxicity.
CBD for Inflammatory Bowel Disease
A study from 2013 on mice that had inflammation similar to IBD induced in their colons revealed that it may help to reduce the production of nitric oxide. It also reduced the inflammation present.
How do I know if CBG works for me?
The best way to start taking it is to find a product that suits your needs. If it’s a muscle problem then maybe topicals may be better suited as the product can target the exact area. If you aren’t a fan of the hemp after-taste then maybe edibles may suit you?
As with CBD, it can take a while to notice the effects of CBG so keeping a note of the effects you do notice is a great way to monitor your intake and the benefits.
It is worth doing your research to find a reputable brand that you can trust. As it is difficult to produce and present in plants at a lower percentage, it may be more expensive to buy. The most common CBG product on the market is oil but there are increasingly other options available including CBG vaping e-liquids.
Is CBG legal?
It is legal, as long as the production does not exceed the legal allowance of THC. THC is still a controlled substance in the UK.
Can CBG get me high?
CBG is non-psychoactive which means they will not get you high like THC can. The same can be said for CBD.
Combining CBD and CBG for the ultimate entourage effect
How much do you know about the 120 different cannabinoids in the cannabis plant? Browns CBD explains how CBD and CBG combine to offer different benefits
The plant actually produces over 120 cannabinoids with some being equally as impressive for certain issues. Browns CBD explains how CBG and CBD combine for the ultimate entourage effect.
By now you will have surely heard of CBD – the hemp-derived compound that has a plethora of health benefits and is incredibly safe to use.
Another important cannabinoid is CBG (Cannabigerol). This cannabinoid is commonly referred to as the ‘mother of all cannabinoids’ as it is the original molecule that most other cannabinoids are synthesized from.
In simple terms, hemp produces CBGa (the acidic form of CBG) in earlier stages of growth which is then converted within the plant into cannabinoids such as THCa, CBDa & CBCa. This can be seen in the diagram below.
CBG tends to be more expensive than CBD due to the fact that most varieties of hemp yield very low levels of CBG. And crops need to be harvested earlier to obtain significant levels of CBG for extraction. However, new CBG rich varieties of hemp are being developed to achieve greater yields.
CBD and CBG benefits
Studies on the benefits of CBG are fairly limited when compared to those of CBD, but there is some very promising preliminary evidence. Anecdotally, we have found customers to be very impressed with its calming effects on a range of issues.
CBG interacts with the endocannabinoid system differently from CBD. For those of you who don’t know, the endocannabinoid system is a significant bodily system made up of endocannabinoids, cannabinoid receptors and enzymes. This system is involved in the proper maintenance of a wide range of bodily functions.
CBD indirectly interacts with these receptors, whereas CBG directly acts upon them. It is through this differentiation of interaction that we believe CBG can have different effects from CBD. A quick search on Google will highlight what these can be.
Our CBG Hemp Oil is rich in CBG, but also in CBD. It has a 1:1 ratio of CBG to CBD in order to have the most significant impact on the endocannabinoid system. Furthermore, it contains both CBD and CBG in its acidic forms and a wide range of additional cannabinoids and terpenes.
Due to the huge variation of compounds within this product, it tends to have more pronounced effects than standard CBD oils of the same strength. Customers tend to be surprised at just how effective it is with the seemingly low 3 per cent concentration.
We believe this is due to the ‘entourage effect’ which is a phenomenon where compounds interact synergistically which results in stronger effects for the user. This has been demonstrated in several studies.
If you are interested in learning more about our CBG Hemp Oil and other effective products, head over to our website today – www.brownscbd.com
Study shows legalisation has no adverse effects on neonatal health outcomes
The team of researchers assessed the influence of statewide cannabis liberalisation policies on newborn health
A new study on the effects of legalising cannabis for adult or therapeutic use shows no adverse effects on neonatal health outcomes at the population level.
The neonatal study was published in the Journal of Health Economics and shows that legalising cannabis for adult use is not associated with adverse effects on neonatal health outcomes.
The team of researchers from Columbia University, University of North Carolina and Indiana University assessed the influence of statewide cannabis liberalisation policies on newborn health over 12 years starting in 2007.
They discovered that the proportion of maternal hospitalisations from cannabis use disorder increased by 23 percent in the first three years of legalisation with larger percentages in states where commercial sales were allowed. This was accompanied by a decrease of 7 percent in tobacco use disorder hospitalisations.
Legalised cannabis was not associated with any significant changes in newborn health according to the study. Medical cannabis laws had no statistically significant effect on maternal substance use disorder hospitalisations or on newborn health.
The authors wrote: “There is no statistically significant effect of medical cannabis laws on the proportion of newborn hospitalisations with prenatal exposure to noxious substances, neonatal drug withdrawal syndrome, fetal alcohol syndrome, slow growth, respiratory conditions, feeding problems, congenital abnormalities, low gestational age, low birth weight, or very low birth weight. Likewise, recreational cannabis laws appear to have no effect on these outcomes.”
They concluded, “In absolute numbers, our findings implied modest or no adverse effects of cannabis liberalisation policies on the array of perinatal outcomes considered.” However, they cautioned, “Our null findings do not refute nor support an argument that prenatal exposure to cannabis has negative effects on newborn health outcomes, but rather that state cannabis liberalisation policies are not associated with net changes at the population-level that are statistically detectable or economically meaningful.”
Other studies assessing the potential effects of cannabis use during perinatal health are inconsistent. Some studies link cannabis use to lower birth weights but failed to adjust methods to account for contributing factors such as tobacco smoking.
A study conducted during the pandemic revealed that cannabis use among pregnant women has increased during lockdown.
Researchers from Kaiser Permanente analysed figures of pregnant women consuming cannabis in Northern California during the pandemic to the numbers from the previous year.
The study involved analysing urine toxicology tests of more than 95,000 women having their first prenatal visit in Northern California Kaiser Permanente. They collected the tests between January 2019 and December 2020 before comparing them to tests from 15 months prior to the start of the pandemic. The results showed a 25 percent increase in the rate of cannabis consumption. Prior to the pandemic, the rates of pregnant women using cannabis were at 6.75 percent. This rose to 8.14 percent during the lockdown.
Introducing our new B2B title
- BPNA publishes new guidance on prescribing medical cannabis in epilepsy
- 71% of CBD users self-determine dosage without professional help
- Menopause: Could CBD offer relief from symptoms?
- “The system needs to change” – Father desperate to access medical cannabis for his disabled son
- “Millions of cannabis patients face criminalisation behind the wheel – even if completely unimpaired”
- CBD guides: Can CBD help with depression?
News11 months ago
Community extends support to cannabis icon Rick Simpson
News1 year ago
NHS lines up cannabis medicine manufacturing
Case Studies2 years ago
CBD oil and fibromyalgia – a case study
News1 year ago
Cancer survivor claims cannabis oil helped her beat brain tumour
Insight1 year ago
I’ve gone from a wheelchair to walking thanks to cannabis
News10 months ago
UK grants second licence to grow high-THC medical cannabis
Feature1 year ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
News11 months ago
Living with chronic fatigue – my CBD story